echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Gene inhibitor helps slow blood clots in COVID-19 patients

    Gene inhibitor helps slow blood clots in COVID-19 patients

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A new study from the Joan .


    The expression of TYMP, a gene that plays an important role in platelet activation, thrombosis and inflammation, was significantly elevated in COVID-19 patient.


    "This study demonstrates for the first time that the SARS-CoV-2 spike protein is sufficient to enhance the expression of TYMP and the activation of NF-kB," said Wei Li, P.


    Li and his team presented the research last month at the International Society of Thrombosis and Hemostasis (ISTH) 2022 Congress in London, Englan.


    Using the human ACE2 gene that mediates SARS-CoV-2 invasion into host cells, transgenic mice, and a mouse thrombosis model, the researchers observed for the first time that intraperitoneal injection of the SARS-CoV-2 spike protein in mice enhanced thrombosis, which could be inhibited by tipiracil, a selective TYMP inhibitor and FDA-approved dru.


    In addition to Li, Renat Roytenberg, Autumn DeHart, D.


    The researchers are looking for partners and collecting patient samples to develop TYMP as a biomarker for diagnosing the severity of COVID-19. Additional ongoing studies are elucidating the mechanisms that mediate the increased expression of TYMP by the SARS-CoV-2 spike protein, and the potential impact of TYMP in prolonged COVID-19.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.